requirements for microalbuminuria are out of touch with the latest science

April 2012

Congratulations to PL editorial advisory board member, Dr. Craig Williams, PharmD, FNLA, BCPS, for his recent Pharmacotherapy editorial. It dispels the common belief that all diabetes patients with microalbuminuria need an ACE inhibitor or ARB, and complements our November 2012 article on the subject. Click here to view Dr. Williams' editorial.

Pay-for-performance requirements for microalbuminuria are out of touch with the latest science.

Many want you to screen diabetes patients for proteinuria every year...and then TREAT microalbuminuria with an ACE inhibitor or ARB even if the patient doesn't have hypertension.

The idea is to slow the progression of kidney disease.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote